About
AmyloiDia is a medtech company founded by researchers from Karolinska Institutet and Stockholm University that builds on our invention of a method that can detect with the ultimate, single-molecule sensitivity structured peptide/protein aggregates called amyloids, and uniquely measure their concentration and size. We focus on the implementation and further advancement of this methodology for applications in biomedical research, pharmaceutical industry and healthcare, most notably for early blood-based diagnosis of amyloid diseases such as Alzheimer's.
Technologies
ApacheGoogle Tag ManagerreCAPTCHATypekitMobile FriendlyVarnishWordPress.org
Keywords
medical equipment manufacturingamyloid nano-plaquesfluorescence correlation spectroscopybiomolecular self-assemblyblood testdisease monitoringbiomarker developmentnon-immune methodamyloid detectionmedical device developmentnano-plaquesalzheimers diseasefluorescence fluctuation analysisnon-radioactive detectionmedical devicesnon-invasive testingmedical and diagnostic laboratoriesspectroscopy methodsmolecular diagnosticsdiagnostic toolssingle-molecule detectionblood-based diagnosissingle-molecule sensitivityblood-based amyloid assayadvanced optical spectroscopymolecular biologymolecular aggregatespre-symptomatic diagnosisbiomarkersearly diagnosis
Company Information
- Employees5
- Founded2019
Location
Visionsgatan, Gothenburg, Vaestra Goetaland County, Sweden, 171 64
